Mark For: BONIFY® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88139466 |
Registration Number | 6059550 |
Mark Literal Elements | BONIFY |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2020-04-15 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | Yes |
Intent To Use | No |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Domestic Representative | Karen Kreider Gaunt |
Attorney Name | Karen Kreider Gaunt |
Attorney Docket Number | 106993-5 |
Law Office Assigned | M10 |
Employee Name | CARLYLE, SHAUNIA P |
2018-10-02 | Application Filed |
2019-08-20 | Published |
2019-08-20 | Published for Opposition |
2019-09-30 | Date of First Use |
2019-09-30 | Date of Use In Commerce |
2019-10-15 | Location: INTENT TO USE SECTION |
2019-10-15 | Status: Live/Pending |
2019-10-15 | Transaction Date |
2020-04-15 | Location: PUBLICATION AND ISSUE SECTION |
2020-05-19 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
2020-05-19 | Trademark Registered |
Party: | ![]() |
Address | Scheelevagen 19 Lund SWEDEN SE-22370 |
Legal Entity Type | Joint Stock Company |
Legal Entity State | SWEDEN |
![]() | JPEG | 2018-10-02 |
![]() | MULTI | 2018-10-02 |
![]() | APPLICATION/XML | 2019-01-17 |
![]() | XML | 2019-01-17 |
![]() | XML | 2019-06-17 |
![]() | MULTI | 2019-06-18 |
![]() | MULTI | 2019-07-06 |
![]() | XML | 2019-07-31 |
![]() | XML | 2019-07-31 |
![]() | APPLICATION/XML | 2019-08-20 |
![]() | APPLICATION/XML | 2019-10-15 |
![]() | JPEG | 2020-03-13 |
![]() | MULTI | 2020-03-13 |
![]() | APPLICATION/XML,IMAGE/JPEG | 2020-04-01 |
![]() | XML | 2020-04-16 |
![]() | MULTI | 2020-04-16 |
![]() | 2020-05-19 |
IC 005. US 006 018 044 046 051 052. G & S: Bone material consisting of natural and biological materials for treatment of osteoporotic fractures; bone filler consisting of natural and biological materials for tissue generation; living tissue, cells and molecules produced in vitro for replacement and support of the function of missing or injured body parts; bone void fillers consisting of natural materials; bone fillers consisting of living materials; bone void fillers consisting of natural and biological materials; bone growth media consisting of biological materials for medical purposes; medical preparations for the treatment of bone diseases; medical preparations for the treatment of bone fractures; osteoconductive materials consisting of natural and biological materials; bone remodeling materials consisting of natural and biological materials; biological preparations for treatment of fractures, osteoporotic fractures, and bone voids caused by trauma, infection, disease or associated surgery; natural biomaterial for augmentation of bone and tissue for medical purposes; biological bone implant material. FIRST USE: 20190930. FIRST USE IN COMMERCE: 20190930
IC 010. US 026 039 044. G & S: Bone substitutes for surgical use; substitutes for bones; non-biological bone implant material; artificial bone parts to be implanted in natural bones; bone substitute material consisting of natural and biological materials. FIRST USE: 20190930. FIRST USE IN COMMERCE: 20190930
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
GS0051 | Bone material consisting of natural and biological materials for treatment of osteoporotic fractures; bone filler consisting of natural and biological materials for tissue generation; living tissue, cells and molecules produced in vitro for replacement and support of the function of missing or injured body parts; bone void fillers consisting of natural materials; bone fillers consisting of living materials; bone void fillers consisting of natural and biological materials; bone growth media consisting of biological materials for medical purposes; medical preparations for the treatment of bone diseases; medical preparations for the treatment of bone fractures; osteoconductive materials consisting of natural and biological materials; bone remodeling materials consisting of natural and biological materials; biological preparations for treatment of fractures, osteoporotic fractures, and bone voids caused by trauma, infection, disease or associated surgery; natural biomaterial for augmentation of bone and tissue for medical purposes; biological bone implant material |
GS0051 | Bone material consisting of natural and biological materials for treatment of osteoporotic fractures; bone filler consisting of natural and biological materials for tissue generation; living tissue, cells and molecules produced in vitro for replacement and support of the function of missing or injured body parts; bone void fillers consisting of natural materials; bone fillers consisting of living materials; bone void fillers consisting of natural and biological materials; bone growth media consisting of biological materials for medical purposes; medical preparations for the treatment of bone diseases; medical preparations for the treatment of bone fractures; osteoconductive materials consisting of natural and biological materials; bone remodeling materials consisting of natural and biological materials; biological preparations for treatment of fractures, osteoporotic fractures, and bone voids caused by trauma, infection, disease or associated surgery; natural biomaterial for augmentation of bone and tissue for medical purposes; biological bone implant material |
Description | Date | Proceeding Number |
---|---|---|
REGISTERED-PRINCIPAL REGISTER | 2020-05-19 | |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2020-04-16 | |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2020-04-15 | |
STATEMENT OF USE PROCESSING COMPLETE | 2020-03-31 | 66230 |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-03-31 | 66230 |
USE AMENDMENT FILED | 2020-03-13 | 66230 |
TEAS STATEMENT OF USE RECEIVED | 2020-03-13 | |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-10-15 | |
PUBLISHED FOR OPPOSITION | 2019-08-20 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-08-20 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-07-31 | |
ASSIGNED TO LIE | 2019-07-15 | 69712 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-07-05 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-06-17 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-06-17 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-06-17 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-01-17 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-01-17 | 74308 |
NON-FINAL ACTION E-MAILED | 2019-01-17 | 6325 |
ASSIGNED TO EXAMINER | 2019-01-14 | 74308 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-10-10 | |
NEW APPLICATION ENTERED IN TRAM | 2018-10-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.